UBS’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$18K Sell
500
-1,500
-75% -$56.6K ﹤0.01% 8150
2014
Q2
$80K Buy
2,000
+500
+33% +$19.2K ﹤0.01% 6226
2014
Q1
$60K Sell
1,500
-2,500
-63% -$90K ﹤0.01% 6605
2013
Q4
$132K Buy
4,000
+2,200
+122% +$68.6K ﹤0.01% 5753
2013
Q3
$53K Sell
1,800
-9,100
-83% -$285K ﹤0.01% 6792
2013
Q2
$367K Buy
+10,900
New +$337K ﹤0.01% 4415

Other funds holding DBD

UBS's DBD Position: Q3 2014 in Review

UBS increased its Diebold Nixdorf Incorporated (DBD) stake by 1.8% in Q3 2014, buying an estimated $52.8K and bringing the position to 81,010 shares worth $2.86M. The position accounts for ﹤0.01% of the portfolio, ranked #2574.

UBS first reported a position in DBD in Q2 2013 and has held it in 6 quarters since. The position peaked at $3.26M in Q1 2014. 254 funds tracked by Wall St. Rank hold DBD as of Q3 2014.

  • UBS held 81,010 shares of Diebold Nixdorf Incorporated worth $2.86M as of Q3 2014.
  • UBS bought 1,400 Diebold Nixdorf Incorporated shares in Q3 2014, an estimated $52.8K.
  • Diebold Nixdorf Incorporated made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2574 holding.
  • UBS first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and has held it in 6 quarters since.
  • UBS's Diebold Nixdorf Incorporated position peaked at $3.26M in Q1 2014.
  • 254 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.